Kerem B - Search Results

1

The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells.

Linde L, Boelz S, Neu-Yilik G, Kulozik AE, Kerem B. Linde L, et al. Among authors: kerem b. Eur J Hum Genet. 2007 Nov;15(11):1156-62. doi: 10.1038/sj.ejhg.5201889. Epub 2007 Jul 11. Eur J Hum Genet. 2007. PMID: 17625509

2

Deletion and insertion mutations in short tandem repeats in the coding regions of human genes.

Darvasi A, Kerem B. Darvasi A, et al. Among authors: kerem b. Eur J Hum Genet. 1995;3(1):14-20. doi: 10.1159/000472269. Eur J Hum Genet. 1995. PMID: 7539330

3

Difference in frequencies of the cystic fibrosis alleles, delta F508 and W1282X, between carriers and patients.

Kalman YM, Kerem E, Darvasi A, DeMarchi J, Kerem B. Kalman YM, et al. Among authors: kerem b, kerem e. Eur J Hum Genet. 1994;2(2):77-82. doi: 10.1159/000472347. Eur J Hum Genet. 1994. PMID: 8044659

4

The molecular basis for disease variability in cystic fibrosis.

Kerem B, Kerem E. Kerem B, et al. Among authors: kerem e. Eur J Hum Genet. 1996;4(2):65-73. doi: 10.1159/000472174. Eur J Hum Genet. 1996. PMID: 8744024 Review.

5

The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

Rave-Harel N, Kerem E, Nissim-Rafinia M, Madjar I, Goshen R, Augarten A, Rahat A, Hurwitz A, Darvasi A, Kerem B. Rave-Harel N, et al. Among authors: kerem b, kerem e. Am J Hum Genet. 1997 Jan;60(1):87-94. Am J Hum Genet. 1997. PMID: 8981951 Free PMC article.

6

Screening of CFTR mutations in an isolated population: identification of carriers and patients.

Chiba-Falek O, Nissim-Rafinia M, Argaman Z, Genem A, Moran I, Kerem E, Kerem B. Chiba-Falek O, et al. Among authors: kerem b, kerem e. Eur J Hum Genet. 1998 Mar-Apr;6(2):181-4. doi: 10.1038/sj.ejhg.5200174. Eur J Hum Genet. 1998. PMID: 9781064

7

Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations.

Nissim-Rafinia M, Chiba-Falek O, Sharon G, Boss A, Kerem B. Nissim-Rafinia M, et al. Among authors: kerem b. Hum Mol Genet. 2000 Jul 22;9(12):1771-8. doi: 10.1093/hmg/9.12.1771. Hum Mol Genet. 2000. PMID: 10915765

8

Splicing regulation as a potential genetic modifier.

Nissim-Rafinia M, Kerem B. Nissim-Rafinia M, et al. Among authors: kerem b. Trends Genet. 2002 Mar;18(3):123-7. doi: 10.1016/s0168-9525(01)02619-1. Trends Genet. 2002. PMID: 11858835 Review.

9

Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.

Linde L, Boelz S, Nissim-Rafinia M, Oren YS, Wilschanski M, Yaacov Y, Virgilis D, Neu-Yilik G, Kulozik AE, Kerem E, Kerem B. Linde L, et al. Among authors: kerem b, kerem e. J Clin Invest. 2007 Mar;117(3):683-92. doi: 10.1172/JCI28523. Epub 2007 Feb 8. J Clin Invest. 2007. PMID: 17290305 Free PMC article.

10

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.

Kerem E, Hirawat S, Armoni S, Yaakov Y, Shoseyov D, Cohen M, Nissim-Rafinia M, Blau H, Rivlin J, Aviram M, Elfring GL, Northcutt VJ, Miller LL, Kerem B, Wilschanski M. Kerem E, et al. Among authors: kerem b. Lancet. 2008 Aug 30;372(9640):719-27. doi: 10.1016/S0140-6736(08)61168-X. Epub 2008 Aug 20. Lancet. 2008. PMID: 18722008 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page